Molecular Diagnostics for Mycobacterium tuberculosis Infection.

Published

Journal Article

Resistance to antimycobacterial drugs is a major barrier to effective treatment of Mycobacterium tuberculosis infection. Molecular diagnostic techniques based on the association between specific gene mutations and phenotypic resistance to certain drugs offer the opportunity to rapidly ascertain whether drug resistance is present and to alter treatment before further resistance develops. Current barriers to successful implementation of rapid diagnostics include imperfect knowledge regarding the full spectrum of mutations associated with resistance, limited utilization of molecular diagnostics where they are most needed, and the requirement for specialized laboratory facilities to perform molecular testing. Further understanding of genotypic-phenotypic correlates of resistance and streamlined implementation platforms will be necessary to optimize the public health impact of molecular resistance testing for M. tuberculosis.

Full Text

Duke Authors

Cited Authors

  • Dicks, KV; Stout, JE

Published Date

  • January 27, 2019

Published In

Volume / Issue

  • 70 /

Start / End Page

  • 77 - 90

PubMed ID

  • 30125128

Pubmed Central ID

  • 30125128

Electronic International Standard Serial Number (EISSN)

  • 1545-326X

Digital Object Identifier (DOI)

  • 10.1146/annurev-med-040717-051502

Language

  • eng

Conference Location

  • United States